Published in Interdiscip Perspect Infect Dis on August 09, 2009
Malaria diagnostics in clinical trials. Am J Trop Med Hyg (2013) 0.95
Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria. Pathog Glob Health (2013) 0.84
Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults. Malar J (2015) 0.81
Malaria and HIV co-infection and their effect on haemoglobin levels from three health-care institutions in Lagos, southwest Nigeria. Afr Health Sci (2013) 0.81
Effect of malaria infection on hematological profiles of people living with human immunodeficiency virus in Gambella, southwest Ethiopia. BMC Hematol (2017) 0.77
Asymptomatic Malaria and Associated Risk Factors among School Children in Sanja Town, Northwest Ethiopia. Int Sch Res Notices (2014) 0.75
Evaluation of a PfHRP-2 based rapid diagnostic test versus microscopy method among HIV-positive and unknown serology patients in Ouagadougou, Burkina Faso. Am J Trop Med Hyg (2015) 0.75
Overview of the effect and epidemiology of parasitic central nervous system infections in African children. Semin Pediatr Neurol (2014) 0.75
A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today (1993) 10.43
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93
Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature (1999) 4.28
Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol (2008) 4.25
Antiretrovirals as antimalarial agents. J Infect Dis (2004) 3.60
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48
Malaria-related anaemia. Parasitol Today (2000) 3.18
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis (2005) 2.51
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS (2004) 2.12
Human cerebral malaria and the blood-brain barrier. Int J Parasitol (2006) 2.05
Effects of early cerebral malaria on cognitive ability in Senegalese children. J Dev Behav Pediatr (2002) 2.02
Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother (2005) 2.00
Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. Lancet (2003) 1.98
The anaemia of P. falciparum malaria. Br J Haematol (1980) 1.97
Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis (2005) 1.81
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun (2009) 1.79
Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol (1993) 1.77
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS (1999) 1.76
HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS (2003) 1.76
Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg (2001) 1.74
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother (2006) 1.72
Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS (2006) 1.71
Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis (2006) 1.57
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
Blood coagulation, inflammation, and malaria. Microcirculation (2008) 1.54
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med (2007) 1.49
Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way. Infect Immun (2000) 1.48
Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J Immunol (2005) 1.48
Red blood cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg (1999) 1.47
Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis (2004) 1.45
Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? Int J Epidemiol (1998) 1.36
Association between malaria and CD4 cell count decline among persons with HIV. J Acquir Immune Defic Syndr (2006) 1.35
Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. J Thromb Haemost (2006) 1.30
Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J Immunol (2006) 1.30
Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J (2003) 1.28
HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. J Infect Dis (2009) 1.24
Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2006) 1.23
Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. J Acquir Immune Defic Syndr (2004) 1.21
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J Neuroimmune Pharmacol (2006) 1.21
Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J (1997) 1.18
CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr (2006) 1.17
Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. Am J Trop Med Hyg (2009) 1.12
Cytoadherence characteristics of Plasmodium falciparum isolates in Thailand using an in vitro human lung endothelial cells model. Am J Trop Med Hyg (2000) 1.08
Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood (2007) 1.07
Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. Int J Parasitol (1996) 1.01
Plasmodium falciparum: role of activated blood monocytes in erythrocyte membrane damage and red cell loss during malaria. Exp Parasitol (1995) 0.97
Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg (2003) 0.96
Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease. Virology (2009) 0.96
Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J Investig Med (2003) 0.93
Proinflammatory response and IL-12 expression in HIV-1 infection. J Leukoc Biol (2000) 0.92
Increased CD36 expression on circulating monocytes during HIV infection. J Acquir Immune Defic Syndr (2005) 0.87
Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria. Clin Vaccine Immunol (2008) 0.86
Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes. Parasitol Int (2006) 0.84
A study of erythroid progenitor cells in the bone marrow of Gambian children with falciparum malaria. Clin Lab Haematol (1988) 0.82
Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum. AIDS (2008) 0.79
Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol (2011) 4.14
Epigenomic modifications predict active promoters and gene structure in Toxoplasma gondii. PLoS Pathog (2007) 1.69
Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat Med (2008) 1.65
An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics (2008) 1.64
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res (2010) 1.64
Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens. Mol Microbiol (2005) 1.45
Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. J Biol Chem (2004) 1.34
Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites. J Infect Dis (2009) 1.28
Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylases. J Biol Chem (2005) 1.28
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem (2004) 1.26
Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum. J Biol Chem (2001) 1.25
The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot Cell (2004) 1.25
Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase. J Biol Chem (2001) 1.24
TgSUB2 is a Toxoplasma gondii rhoptry organelle processing proteinase. Mol Microbiol (2003) 1.19
Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii. Mol Biochem Parasitol (2006) 1.14
Toxoplasma gondii sequesters centromeres to a specific nuclear region throughout the cell cycle. Proc Natl Acad Sci U S A (2011) 1.14
Computational analysis and experimental validation of gene predictions in Toxoplasma gondii. PLoS One (2008) 1.08
Toxoplasma gondii and Cryptosporidium parvum lack detectable DNA cytosine methylation. Eukaryot Cell (2008) 1.03
Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus. Int J Parasitol (2004) 1.03
Toxoplasma gondii protease TgSUB1 is required for cell surface processing of micronemal adhesive complexes and efficient adhesion of tachyzoites. Cell Microbiol (2010) 1.01
Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. J Biol Chem (2008) 1.01
The Toxoplasma nuclear factor TgAP2XI-4 controls bradyzoite gene expression and cyst formation. Mol Microbiol (2012) 1.01
Location, location, location: trafficking and function of secreted proteases of Toxoplasma and Plasmodium. Traffic (2004) 1.00
Proteolytic processing of the Cryptosporidium glycoprotein gp40/15 by human furin and by a parasite-derived furin-like protease activity. Infect Immun (2006) 1.00
Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics (2010) 1.00
Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii. Int J Parasitol (2005) 0.99
EPIC-DB: a proteomics database for studying Apicomplexan organisms. BMC Genomics (2009) 0.96
The prodomain of Toxoplasma gondii GPI-anchored subtilase TgSUB1 mediates its targeting to micronemes. Traffic (2008) 0.95
Structural and metabolic specificity of methylthiocoformycin for malarial adenosine deaminases. Biochemistry (2009) 0.95
Cyclin-dependent kinase TPK2 is a critical cell cycle regulator in Toxoplasma gondii. Mol Microbiol (2002) 0.94
High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development. J Biol Chem (2008) 0.94
Plasmodium protease ROM1 is important for proper formation of the parasitophorous vacuole. PLoS Pathog (2011) 0.93
The histone code of Toxoplasma gondii comprises conserved and unique posttranslational modifications. MBio (2013) 0.93
Chromatin modifications, epigenetics, and how protozoan parasites regulate their lives. Trends Parasitol (2012) 0.93
Analysis of the glycoproteome of Toxoplasma gondii using lectin affinity chromatography and tandem mass spectrometry. Microbes Infect (2011) 0.90
Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection. J Infect Dis (2003) 0.90
Toxoplasma gondii purine nucleoside phosphorylase biochemical characterization, inhibitor profiles, and comparison with the Plasmodium falciparum ortholog. J Biol Chem (2006) 0.90
Plasmodium falciparum: growth response to potassium channel blocking compounds. Exp Parasitol (2008) 0.90
Toxoplasma gondii proteomics. Expert Rev Proteomics (2009) 0.89
Toxoplasma transcription factor TgAP2XI-5 regulates the expression of genes involved in parasite virulence and host invasion. J Biol Chem (2013) 0.89
Characterization of two putative potassium channels in Plasmodium falciparum. Malar J (2008) 0.89
Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. Mol Biochem Parasitol (2007) 0.88
Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukaryot Cell (2009) 0.88
Imaging devices for use in small animals. Semin Nucl Med (2011) 0.87
HIV in the tropics: staging in the resource-limited setting. Curr Opin Infect Dis (2012) 0.87
Discovery of a splicing regulator required for cell cycle progression. PLoS Genet (2013) 0.86
A nucleolar AAA-NTPase is required for parasite division. Mol Microbiol (2013) 0.83
The unfolded protein response in the protozoan parasite Toxoplasma gondii features translational and transcriptional control. Eukaryot Cell (2013) 0.83
How epigenomics contributes to the understanding of gene regulation in Toxoplasma gondii. J Eukaryot Microbiol (2009) 0.82
Improved techniques for endogenous epitope tagging and gene deletion in Toxoplasma gondii. J Microbiol Methods (2011) 0.82
Compton scattering by internal shields based on melanin-containing mushrooms provides protection of gastrointestinal tract from ionizing radiation. Cancer Biother Radiopharm (2012) 0.81
New eukaryotic systematics: a phylogenetic perspective of developmental gene expression in the Apicomplexa. Int J Parasitol (2008) 0.81
Time to screen for congenital toxoplasmosis? Clin Infect Dis (2006) 0.80
The International Congress on Toxoplasmosis. Int J Parasitol (2004) 0.80
The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis. J Neuroparasitology (2012) 0.79
Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase. Eukaryot Cell (2014) 0.79
Role of the parafusin orthologue, PRP1, in microneme exocytosis and cell invasion in Toxoplasma gondii. Cell Microbiol (2003) 0.78
Techniques to study epigenetic control and the epigenome in parasites. Methods Mol Biol (2015) 0.75